$TAUG Tauriga Sciences Inc. Prepares for Major Upc
Post# of 165
(Total Views: 356)
Posted On: 05/27/2021 11:51:41 AM
$TAUG Tauriga Sciences Inc. Prepares for Major Upcoming Product Launch and Introduces Expanded Tauri-Gummies™ Product Line
https://www.globenewswire.com/news-release/20...-Line.html
NEW YORK, NY, May 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced its preparations for its major upcoming product launch as well as the expansion of its Tauri-Gummies™ product line. The Company has worked with great diligence to be Innovative, with respect to the enhancement of its products and product lines. The Company is confident in its ability to gain market share and is continuing to increase its salesforce and its visibility to a broad array of potential new customers.
The Company is making final preparations for the upcoming launch of its enhanced Tauri-Gum™ product line (its flagship product line). Expected to occur during early June 2021, this product launch will include: 5 SKUs of 25mg CBD & CBG infused chewing gum, 1 SKU of 10mg Delta 8 THC infused chewing gum, 3 SKUs of Cannabinoid free chewing gum (Vitamin C + Zinc, Caffeine, Vitamin D3) and 2 SKUs pursuant to License Agreement (to be disclosed within the near term).
The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies™ product line. This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.
Additionally, the Company is pleased to announce its plans to open its first retail location. Once finalized, the Company will notify shareholders about the specific details. Due to the Company’s strong balance sheet and liquidity, the Company has the flexibility to pursue multiple opportunities to grow revenue, brand exposure, and material partnerships.
In other news, the Company continues to realize important progress, with respect to its Pharmaceutical development efforts. The Company has assembled an experienced and highly qualified clinical development team and expects to provide update(s) to shareholders within the near term.
https://www.globenewswire.com/news-release/20...-Line.html
NEW YORK, NY, May 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced its preparations for its major upcoming product launch as well as the expansion of its Tauri-Gummies™ product line. The Company has worked with great diligence to be Innovative, with respect to the enhancement of its products and product lines. The Company is confident in its ability to gain market share and is continuing to increase its salesforce and its visibility to a broad array of potential new customers.
The Company is making final preparations for the upcoming launch of its enhanced Tauri-Gum™ product line (its flagship product line). Expected to occur during early June 2021, this product launch will include: 5 SKUs of 25mg CBD & CBG infused chewing gum, 1 SKU of 10mg Delta 8 THC infused chewing gum, 3 SKUs of Cannabinoid free chewing gum (Vitamin C + Zinc, Caffeine, Vitamin D3) and 2 SKUs pursuant to License Agreement (to be disclosed within the near term).
The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies™ product line. This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.
Additionally, the Company is pleased to announce its plans to open its first retail location. Once finalized, the Company will notify shareholders about the specific details. Due to the Company’s strong balance sheet and liquidity, the Company has the flexibility to pursue multiple opportunities to grow revenue, brand exposure, and material partnerships.
In other news, the Company continues to realize important progress, with respect to its Pharmaceutical development efforts. The Company has assembled an experienced and highly qualified clinical development team and expects to provide update(s) to shareholders within the near term.
(0)
(0)Tauriga Sciences, Inc. (TAUG) Stock Research Links
Scroll down for more posts ▼